Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cerevel Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERE
)
44.96
UNCHANGED
Last Price
Updated: 4:15 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerevel Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Top 5 Health Care Stocks That Should Keep You Up At Night
↗
May 23, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
↗
May 04, 2023
Via
Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
↗
May 04, 2023
Via
Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
↗
May 04, 2023
Via
Benzinga
Cerevel Therapeutics Hldg: Q1 Earnings Insights
↗
May 03, 2023
Via
Benzinga
Where Cerevel Therapeutics Hldg Stands With Analysts
↗
April 03, 2023
Via
Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
↗
March 09, 2023
Via
Benzinga
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
↗
December 19, 2022
Via
Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
↗
December 06, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
↗
April 10, 2023
Via
Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
↗
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
↗
September 13, 2022
Analysts have provided the following ratings for Cerevel Therapeutics Hldg (NASDAQ:CERE) within the last quarter:
Via
Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
↗
August 23, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
↗
March 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
↗
February 23, 2023
Via
Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
February 22, 2023
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous...
Via
Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
↗
February 03, 2023
Via
Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
↗
December 19, 2022
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
↗
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
↗
November 09, 2022
Over the past 3 months, 8 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
↗
November 09, 2022
B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading.
Via
Benzinga
Why Cerevel Therapeutics Holdings Shares Are Nosediving
↗
November 08, 2022
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 6.42% to $25.37 during Tuesday's session after the company reported worse-than-expected third-quarter EPS results and filed...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
↗
November 01, 2022
Upgrades
Via
Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
↗
October 20, 2022
Cerevel Therapeutics Hldg (NASDAQ:CERE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
↗
October 20, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
↗
September 29, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
↗
September 29, 2022
Over the past 3 months, 8 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
↗
September 26, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
↗
September 13, 2022
Upgrades See all analyst ratings upgrades.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
